PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
68.30%
Net income growth 1.25-1.5x MCHP's 58.52%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
-0.61%
Both reduce yoy D&A, with MCHP at -0.69%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
625.00%
Some yoy growth while MCHP is negative at -94.68%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-7.25%
Negative yoy SBC while MCHP is 5.10%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-10.48%
Negative yoy working capital usage while MCHP is 160.66%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-339.68%
AR is negative yoy while MCHP is 457.73%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
64.84%
Inventory growth well above MCHP's 59.36%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
-251.35%
Both negative yoy AP, with MCHP at -177.33%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
155.86%
Growth well above MCHP's 60.89%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
50.33%
Operating cash flow growth at 50-75% of MCHP's 85.77%. Martin Whitman would worry about lagging operational liquidity vs. competitor.
-41.75%
Negative yoy CapEx while MCHP is 7.31%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
100.00%
Acquisition growth of 100.00% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-70.78%
Both yoy lines negative, with MCHP at -5.87%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
43.18%
Proceeds from sales/maturities above 1.5x MCHP's 12.66%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
-100.00%
We reduce yoy other investing while MCHP is 7.48%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
18.89%
Investing outflow well above MCHP's 18.50%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-91.67%
We cut debt repayment yoy while MCHP is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-73.75%
Both yoy lines negative, with MCHP at -59.53%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
No Data
No Data available this quarter, please select a different quarter.